GALT

Galectin Therapeutics Inc

3.940

+0.300+8.24%

After Hours: 3.940 0.000 0.00%19:30 10/09 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE3.640/3.640

TODAY RANGE3.640-3.970

VOL156.51K

MARKET CAP397.35M

52 WEEK RANGE2.025-7.13

AVG VOL (3M)377.64K

% TURNOVER0.14%

TURNOVER--

P/E (TTM)-9.1564

% RANGE9.07%

EPS(TTM)-0.4303

P/E(FORWARD)-13.1333

P/B-1.9091

BVPS-2.0638

DIVIDEND--

P/S--

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP186.43M

SHARES OUTSTANDING100.85M

NEXT EARNINGS11/12-11/16

FREE FLOAT47.32M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

Seeking Alpha·4d ago
Galectin: $105M Debt Conversion Clears The Balance Sheet, But Phase 3 Partnership Is Critical
Benzinga·09/15 21:06
12 Health Care Stocks Moving In Tuesday's After-Market Session
NASDAQ·08/19 07:15
Galectin Loss Widens In Q2; Plans Phase 3 MASH Trial For Q3 2026
TipRanks·08/14 15:25
Buy Rating Reaffirmed on GALT as Belapectin Program De-Risked; $11 Price Target Maintained
Dow Jones·08/14 14:55
Galectin Shares Slip on Wider Second-Quarter Loss
Seeking Alpha·08/14 14:16
Galectin Therapeutics reports Q2 results
Benzinga·08/14 12:13
Galectin Therapeutics Q2 EPS $(0.14) Misses $(0.09) Estimate
Dow Jones·08/14 12:00
*Galectin Therapeutics 2Q Research and Development Expenses $2.1M >GALT
Dow Jones·08/14 12:00
Press Release: Galectin Therapeutics Reports June -2-
Dow Jones·08/14 12:00
*Galectin Therapeutics 2Q Loss/Shr 14c >GALT
Dow Jones·08/14 12:00
Press Release: Galectin Therapeutics Reports June 30, 2026 Financial Results and Provides Business Update
TipRanks·08/04 12:19
Galectin Therapeutics strengthens balance sheet via debt-to-equity conversion
Benzinga·08/04 12:05
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga·08/04 12:05
Galectin Therapeutics Converts ~$105.8M Of Debt Into ~34.4M Shares At Blended Average Conversion Price Of ~$3.07 Per Share
Dow Jones·08/04 12:02
*Galectin Therapeutics Announces Conversion of $105.8M in Debt to Equity, Significantly Strengthening Balance Sheet

Same Industry

Name/Symbol

Change%

Price

GALT

Regeneron Pharmaceuticals

REGN

+0.94%

746.54

GRDX

BNTX

United Therapeutics Corp.

UTHR

+3.07%

549.16

VRTX

SIGA

MRNA

CRL

MEDP

TLPH

ICLR

China Biologic

CBPO

0.00%

119.99

Iqvia Hldgs Inc

IQV

+0.39%

259.88

MOLN

ARCT

Gilead Sciences Inc

GILD

+2.77%

151.17

PRAH

INCY

APVO

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.